Skip to content

Young Houston Emergency Opioid Engagement System

Houston Emergency Engagement System for Youths and Adolescents

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04811014
Acronym
YHEROES
Enrollment
250
Registered
2021-03-23
Start date
2021-04-19
Completion date
2030-08-31
Last updated
2025-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid-use Disorder, Opioid Dependence, Opioid Overdose, Opioid Use, Substance Use Disorders

Brief summary

The Houston Emergency Response Opioid Engagement System for Youths and Adolescents (Young HEROES) is a community-based research program integrating assertive outreach, medication for opioid use disorder (MOUD), behavioral counseling, and peer recovery support. The objective is to compare differences in engagement and retention in treatment for individuals with opioid use disorder. The investigators also intend to understand the prevalence of opioid overdoses and OUD among youth in Houston.

Detailed description

The Houston Emergency Response Opioid Engagement System for Youths and Adolescents (Young HEROES) is a non-randomized cohort study based at the University of Texas Health Science Center of Houston. This study recruits participants through three avenues: assertive community outreach with a peer coach and paramedic following and opioid overdose, community referrals, and emergency department referrals. The study explores the effect of the combination of assertive outreach, same-day induction into medication for opioid use disorder, ongoing maintenance treatment, behavioral counseling, peer recovery support, and paramedic follow-up on patient outcomes. The primary outcome is engagement and retention in outpatient treatment. Secondary outcomes include quality of life assessment as well as subsequent relapses and overdoses. The hypothesis is that patients with earlier induction into MOUD treatment who receive routine follow-up, are more likely to engage and remain in treatment long-term.

Interventions

DRUGBuprenorphine, Naloxone Drug Combination

8mg of buprenorphine/2mg of naloxone to initiate MOUD treatment and bridge, if necessary, until referral to MOUD clinic can be made for ongoing treatment

One-on-one counseling with a licensed chemical dependency counselor

BEHAVIORALPeer Recovery Support Services

24/7 support from our team of certified peer recovery support specialists to assist with emotional support and case management

BEHAVIORALSupport Group

Referrals to youth-focused support groups and eventual creation of in-house youth-focused support groups

BEHAVIORALReferral to Medication Management

Study staff will refer patients to long-term MOUD providers in the community

BEHAVIORALAssertive Outreach

The investigators will conduct weekly outreach to youths who experienced an opioid overdose and attempt to initiate treatment. Outreach is completed by a paramedic and peer coach.

Sponsors

The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* In otherwise good health based on physician assessment and medical history * Drug screen positive for opioids * Patients express a willingness to stop opioid use * Meet Diagnostic and Statistical Manual of Mental Disorders - Text Revision (DSM-IV-TR) criteria for opioid dependence * Patients must be able to speak English * Be agreeable to and capable of signing the informed consent and assent (parent or guardian must consent, minor must assent)

Exclusion criteria

* Non-English-speaking patients * Have a known sensitivity to buprenorphine or naloxone * Be physiologically dependent on alcohol, benzodiazepines, or other drugs of abuse that require immediate medical attention. Other substance use diagnoses are not exclusionary. * Have a medical condition that would, in the opinion of the study physician, make participation medically hazardous, including unstable cardiovascular disease, neurological deficits, trauma, acute hepatitis, stroke, and liver or renal disease) * Be acutely psychotic, severely depressed, and in need of inpatient treatment, or is an immediate suicide risk * Be a nursing or pregnant female

Design outcomes

Primary

MeasureTime frameDescription
Patient retention in treatment30 days after enrollmentPercentage of enrolled youth in treatment over time
Patient abstinence from opioids30 days after enrollmentDays without substance use

Secondary

MeasureTime frameDescription
Frequency of opioid emergencies among adolescents in Houston, TexasThrough study completion, an average of 3 yearsPrevalence of opioid overdoses among youth

Countries

United States

Contacts

Primary ContactJames R Langabeer, PhD
james.r.langabeer@uth.tmc.edu713-500-3925
Backup ContactMeredith M O'Neal, MA
meredith.m.oneal@uth.tmc.edu713-500-3624

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026